US2014039022A1PendingUtilityA1
Manufacture, compositions and uses of coagulation factor viia modulator
Est. expiryOct 16, 2027(~1.2 yrs left)· nominal 20-yr term from priority
A61K 41/00A61K 31/4184C07D 235/18A61P 43/00A61P 35/00A61P 35/04A61K 45/06C07D 209/00A61P 7/02A61P 35/02C07D 235/12A61K 31/4164
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Treatment of cancer and thromboembolic disorders using inhibitors of Factor VIIa are disclosed herein using a compound of Formula I:
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A solution comprising:
a) a compound of Formula I or a salt thereof:
and
b) a thrombin modulator;
wherein the compound of Formula I and the thrombin modulator are in solution.
2 . A composition comprising:
a) a compound of Formula I or a salt thereof:
and
b) an amino acid buffer.
3 . A combined dosage comprising:
a) a compound of Formula I or a salt thereof:
and
b) an additional therapeutic agent;
wherein the compound of Formula I and the additional therapeutic agent are in a combined dosage form.
4 . A composition comprising:
a) a compound of Formula I or a salt thereof:
b) a pH adjusting agent;
wherein the pH of the composition is between 7 and 9.
5 . A kit comprising, a container comprising:
a) a compound of Formula I or a salt thereof:
and
b) an additional therapeutic agent; and
c) a buffer and/or diluent.Join the waitlist — get patent alerts
Track US2014039022A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.